Medifast Company Profile (NYSE:MED)

About Medifast (NYSE:MED)

Medifast logoMedifast, Inc. is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. The Company provides weight loss, weight management and healthy living products and programs through multiple channels of distribution, which include Take Shape For Life; its direct to consumer business unit through its Website and in-house call centers; Franchise Medifast Weight Control Centers, and a national network of physicians. The Company offers a range of weight loss, weight management and healthy products under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home and Essential 1 brands. The Company also offers a sports nutrition pilot product line, Dual Fuel.

Industry, Sector and Symbol:
  • Sector: Consumer Staples
  • Industry: Special Foods & Welbeing Products
  • Sub-Industry: Personal Products
  • Symbol: NYSE:MED
  • CUSIP: 58470H10
  • Web:
  • Market Cap: $687.77 million
  • Outstanding Shares: 11,930,000
Average Prices:
  • 50 Day Moving Avg: $52.60
  • 200 Day Moving Avg: $45.49
  • 52 Week Range: $36.70 - $58.64
  • Trailing P/E Ratio: 28.97
  • Foreward P/E Ratio: 23.01
  • P/E Growth: 1.78
Sales & Book Value:
  • Annual Revenue: $277.4 million
  • Price / Sales: 2.47
  • Book Value: $8.73 per share
  • Price / Book: 6.59
  • Annual Dividend: $1.28
  • Dividend Yield: 2.2%
  • EBIDTA: $40.01 million
  • Net Margins: 8.62%
  • Return on Equity: 24.25%
  • Return on Assets: 19.24%
  • Current Ratio: 4.40%
  • Quick Ratio: 3.69%
  • Average Volume: 105,117 shs.
  • Beta: 0.43
  • Short Ratio: 0.17

Frequently Asked Questions for Medifast (NYSE:MED)

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Thursday, September 7th. Investors of record on Friday, September 22nd will be given a dividend of $0.32 per share on Thursday, November 9th. This represents a $1.28 annualized dividend and a yield of 2.23%. The ex-dividend date of this dividend is Thursday, September 21st. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) released its quarterly earnings data on Tuesday, August, 8th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.53 by $0.10. The business earned $75.70 million during the quarter, compared to the consensus estimate of $71.96 million. Medifast had a net margin of 8.62% and a return on equity of 24.25%. The company's revenue was up 6.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.63 EPS. View Medifast's Earnings History.

When will Medifast make its next earnings announcement?

Medifast is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast issued an update on its FY17 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $2.05-$2.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.02. The company issued revenue guidance of $290-$300 million, compared to the consensus revenue estimate of $288.65 million.Medifast also updated its Q3 guidance to $0.48-$0.51 EPS.

Where is Medifast's stock going? Where will Medifast's stock price be in 2017?

2 brokerages have issued 1 year target prices for Medifast's shares. Their predictions range from $74.00 to $74.00. On average, they expect Medifast's share price to reach $74.00 in the next year. View Analyst Ratings for Medifast.

Who are some of Medifast's key competitors?

Who are Medifast's key executives?

Medifast's management team includes the folowing people:

  • Michael Charles MacDonald, Executive Chairman of the Board
  • Daniel R. Chard, Chief Executive Officer, Director
  • Timothy G. Robinson CPA, Chief Financial Officer
  • Jason L. Groves Esq., Executive Vice President, General Counsel
  • Joseph P. Kelleman, Vice President - Finance, CorporateController
  • Kevin G. Byrnes, Independent Director
  • Charles P. Connolly, Independent Director
  • Carl E. Sassano, Independent Director

Who owns Medifast stock?

Medifast's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (8.02%), Dimensional Fund Advisors LP (5.53%), Vanguard Group Inc. (5.51%), Acadian Asset Management LLC (3.91%), Kennedy Capital Management Inc. (3.34%) and State Street Corp (2.70%). Company insiders that own Medifast stock include Balanced Master Fund L Visium, Glenn W Welling, Jeffrey J Brown and Margaret Sheetz. View Institutional Ownership Trends for Medifast.

Who sold Medifast stock? Who is selling Medifast stock?

Medifast's stock was sold by a variety of institutional investors in the last quarter, including Numeric Investors LLC, GSA Capital Partners LLP, Menta Capital LLC, TIAA CREF Investment Management LLC, Wells Fargo & Company MN, Russell Investments Group Ltd., First Quadrant L P CA and Prudential Financial Inc.. View Insider Buying and Selling for Medifast.

Who bought Medifast stock? Who is buying Medifast stock?

Medifast's stock was acquired by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Goldman Sachs Group Inc., American Century Companies Inc., Citadel Advisors LLC, Schroder Investment Management Group, Dimensional Fund Advisors LP, Dean Capital Management and LSV Asset Management. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling and Jeffrey J Brown. View Insider Buying and Selling for Medifast.

How do I buy Medifast stock?

Shares of Medifast can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of Medifast stock can currently be purchased for approximately $57.52.

MarketBeat Community Rating for Medifast (NYSE MED)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  127 (Vote Outperform)
Underperform Votes:  150 (Vote Underperform)
Total Votes:  277
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Medifast (NYSE:MED) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $74.00 (28.65% upside)

Analysts' Ratings History for Medifast (NYSE:MED)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/15/2017DA DavidsonBoost Price TargetBuy -> Buy$65.00 -> $74.00HighView Rating Details
5/2/2017SidotiDowngradeBuy -> NeutralLowView Rating Details
8/4/2016WunderlichBoost Price TargetHold$32.00 -> $36.00N/AView Rating Details
11/8/2015Canaccord GenuityReiterated RatingHold$33.00N/AView Rating Details
(Data available from 9/21/2015 forward)


Earnings History for Medifast (NYSE:MED)
Earnings by Quarter for Medifast (NYSE:MED)
Earnings History by Quarter for Medifast (NYSE MED)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2017Q2 2017$0.53$0.63$71.96 million$75.70 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.49$0.51$72.36 million$70.62 millionViewListenView Earnings Details
3/9/2017Q4 2016$0.33$0.34$65.01 million$62.50 millionViewListenView Earnings Details
11/3/2016Q316$0.45$0.51$66.79 million$68.57 millionViewN/AView Earnings Details
8/3/2016Q216$0.51$0.63$72.01 million$71.14 millionViewN/AView Earnings Details
5/4/2016Q116$0.33$0.42$69.31 million$72.30 millionViewN/AView Earnings Details
3/10/2016Q415$0.35$0.33$62.98 million$61.30 millionViewListenView Earnings Details
11/5/2015Q315$0.42$0.45$67.00 million$65.90 millionViewN/AView Earnings Details
8/5/2015Q215$0.48$0.48$72.79 million$72.20 millionViewN/AView Earnings Details
5/7/2015Q115$0.35$0.46$71.80 million$73.30 millionViewN/AView Earnings Details
3/12/2015Q414$0.46$0.38$69.40 million$62.30 millionViewN/AView Earnings Details
11/5/2014Q314$0.36$0.47$76.10 million$74.00 millionViewN/AView Earnings Details
8/7/2014Q114$0.40$0.44$87.30 million$80.88 millionViewN/AView Earnings Details
5/5/2014Q1$0.37$0.45$87.60 million$86.50 millionViewN/AView Earnings Details
3/10/2014Q413$0.36$0.39$80.83 million$77.30 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.41$95.07 million$86.48 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.51$0.51$101.30 million$97.10 millionViewN/AView Earnings Details
5/8/2013Q1 2013$0.34$0.43$93.77 million$96.00 millionViewN/AView Earnings Details
3/7/2013Q4 2012$0.25$0.28$82.90 million$83.20 millionViewN/AView Earnings Details
11/5/2012Q312$0.40$0.42$89.73 million$91.00 millionViewN/AView Earnings Details
7/26/2012$0.38$0.47ViewN/AView Earnings Details
5/8/2012$0.38$0.29ViewN/AView Earnings Details
3/13/2012$0.21$0.08ViewN/AView Earnings Details
11/3/2011$0.38$0.36ViewN/AView Earnings Details
8/4/2011$0.47$0.41ViewN/AView Earnings Details
5/9/2011$0.41$0.44ViewN/AView Earnings Details
3/31/2011$0.32$0.23ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Medifast (NYSE:MED)
2017 EPS Consensus Estimate: $0.98
2018 EPS Consensus Estimate: $2.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20171$0.51$0.51$0.51
Q4 20171$0.47$0.47$0.47
Q1 20181$0.58$0.58$0.58
Q2 20181$0.74$0.74$0.74
Q3 20181$0.61$0.61$0.61
Q4 20181$0.57$0.57$0.57
(Data provided by Zacks Investment Research)


Current Dividend Information for Medifast (NYSE:MED)
Next Dividend:11/9/2017
Annual Dividend:$1.28
Dividend Yield:2.23%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:64.32% (Trailing 12 Months of Earnings)
60.38% (Based on This Year's Estimates)
51.20% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Medifast (NYSE:MED)

Dividend History by Quarter for Medifast (NYSE MED)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Medifast (NYSE:MED)
Insider Ownership Percentage: 6.47%
Institutional Ownership Percentage: 89.48%
Insider Trades by Quarter for Medifast (NYSE:MED)
Institutional Ownership by Quarter for Medifast (NYSE:MED)
Insider Trades by Quarter for Medifast (NYSE:MED)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/14/2017Glenn W WellingDirectorBuy17,084$41.33$706,081.72View SEC Filing  
11/15/2016Glenn W WellingDirectorBuy35,000$39.02$1,365,700.00View SEC Filing  
11/9/2016Jeffrey J BrownDirectorBuy10,000$38.71$387,100.00View SEC Filing  
5/31/2016Balanced Master Fund L VisiumMajor ShareholderSell1,350,000$30.25$40,837,500.00View SEC Filing  
4/1/2016Margaret SheetzCOOSell8,333$30.02$250,156.66View SEC Filing  
2/1/2016Margaret SheetzCOOSell8,333$28.62$238,490.46View SEC Filing  
12/1/2015Margaret SheetzCOOSell8,333$29.92$249,323.36View SEC Filing  
11/2/2015Margaret SheetzCOOSell8,333$28.72$239,323.76View SEC Filing  
10/5/2015Margaret SheetzCOOSell8,333$28.88$240,657.04View SEC Filing  
9/3/2015Margaret SheetzCOOSell6,864$28.00$192,192.00View SEC Filing  
9/2/2015Margaret SheetzCOOSell1,469$28.00$41,132.00View SEC Filing  
6/25/2015Moduslink Global Solutions IncMajor ShareholderSell29,654$33.03$979,471.62View SEC Filing  
6/23/2015Moduslink Global Solutions IncMajor ShareholderSell27,443$33.01$905,893.43View SEC Filing  
6/22/2015Moduslink Global Solutions IncMajor ShareholderSell9,494$33.01$313,396.94View SEC Filing  
6/11/2015Barry B BondroffDirectorSell1,666$31.88$53,112.08View SEC Filing  
6/10/2015Margaret SheetzCOOSell8,337$32.00$266,784.00View SEC Filing  
6/4/2015John P McdanielDirectorSell3,000$32.14$96,420.00View SEC Filing  
8/18/2014Jeannette M MillsEVPSell3,000$28.03$84,090.00View SEC Filing  
6/10/2014Jason L GrovesEVPSell3,250$31.75$103,187.50View SEC Filing  
6/10/2014John P McdanielDirectorSell3,500$31.74$111,090.00View SEC Filing  
6/9/2014Jeannette M MillsEVPSell2,784$32.09$89,338.56View SEC Filing  
6/5/2014Charles P ConnollyDirectorSell7,500$30.91$231,825.00View SEC Filing  
12/2/2013Margaret Macdonald SheetzCOOSell18,000$25.63$461,340.00View SEC Filing  
11/22/2013Margaret Macdonald SheetzCOOSell35,000$24.33$851,550.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Medifast (NYSE:MED)
Latest Headlines for Medifast (NYSE:MED)
DateHeadline logoETFs with exposure to Medifast, Inc. : September 19, 2017 - September 20 at 6:16 AM logoMedifast® Announces New Corporate Headquarters in Baltimore City - September 18 at 9:16 PM logoMedifast confirms headquarters move to Harbor East - September 18 at 9:16 PM logoMedifast, Inc. :MED-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017 - September 18 at 9:16 PM logoDA Davidson Comments on Medifast Inc's FY2019 Earnings (MED) - September 18 at 9:06 AM logoMedifast Inc (MED) Price Target Raised to $74.00 at DA Davidson - September 15 at 8:00 PM logoMedifast Inc Plans Quarterly Dividend of $0.32 (MED) - September 7 at 5:28 PM logoMEDIFAST INC (MED) Forecasted to Earn Q3 2017 Earnings of $0.51 Per Share - August 21 at 2:52 AM logoMedifast Inc (MED) Raised to "Hold" at BidaskClub - August 19 at 4:38 PM logoBloomberg Markets: Dave Wilson’s Stock of the Day for Aug. 17 - August 18 at 6:42 AM logoStock Indexes Retreat Fast; Medifast Thrusts Higher - August 18 at 6:42 AM logoMedifast, Inc. – Value Analysis (NYSE:MED) : August 17, 2017 - August 17 at 2:33 AM logoMedifast Inc (MED) Now Covered by Analysts at DA Davidson - August 16 at 5:40 PM logoMedifast Inc (MED) Upgraded at BidaskClub - August 13 at 9:02 AM logoMedifast stock skyrockets 13 percent to $50 per share after earnings beat Wall Street estimates - August 11 at 6:28 AM logoMedifast, Inc.: Gathering momentum, can it sustain its performance? - August 11 at 6:28 AM logoEdited Transcript of MED earnings conference call or presentation 8-Aug-17 8:30pm GMT - August 10 at 5:02 AM logoMedifast's (MED) CEO Daniel Chard on Q2 2017 Results - Earnings Call Transcript - August 8 at 11:31 PM logoInvestor Network: Medifast, Inc. to Host Earnings Call - August 8 at 11:31 PM logoMedifast, Inc. Announces Second Quarter 2017 Financial Results - August 8 at 11:31 PM logoMedifast posts 2Q profit - August 8 at 11:31 PM logoMEDIFAST INC (MED) Posts Earnings Results, Beats Estimates By $0.11 EPS - August 8 at 6:30 PM logoMEDIFAST INC (NYSE:MED) Issues Q3 Earnings Guidance - August 8 at 5:38 PM logoMEDIFAST INC (MED) Updates FY17 Earnings Guidance - August 8 at 5:38 PM logoMedifast, Inc. breached its 50 day moving average in a Bearish Manner : MED-US : August 4, 2017 - August 5 at 2:45 AM logoMEDIFAST INC (NYSE:MED) to Release Quarterly Earnings on Tuesday - August 1 at 9:39 AM logoGlobal Weight Loss and Diet Management Market - Industry Forecast to 2025 - Huge Growth Potential from Developing Economies - July 25 at 11:55 PM logoTake Shape For Life® Rebrands to OPTAVIA™ - July 24 at 1:35 PM logoWhen it comes to CEO pay, performance matters - July 23 at 5:17 AM logoMEDIFAST INC (NYSE:MED) vs. Nutraceutical International Corporation (NUTR) Financial Review - July 20 at 5:21 PM logoMedifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2017 - July 18 at 11:18 PM logoMEDIFAST INC (NYSE:MED) & Nutraceutical International Corporation (NUTR) Head to Head Analysis - July 17 at 9:54 AM logoHead to Head Analysis: Nutraceutical International Corporation (NUTR) vs. MEDIFAST INC (MED) - July 14 at 8:50 AM logoFinancial Analysis: MEDIFAST INC (NYSE:MED) & Nutraceutical International Corporation (NUTR) - July 8 at 8:24 AM logoETFs with exposure to Medifast, Inc. : July 6, 2017 - July 7 at 7:22 AM logoComparing MEDIFAST INC (NYSE:MED) and Nutraceutical International Corporation (NUTR) - July 6 at 7:42 AM logoComparing Nutraceutical International Corporation (NUTR) and Medifast (MED) - July 4 at 12:14 AM logo Brokerages Expect Medifast Inc (MED) to Post $0.53 EPS - June 28 at 12:30 AM logoMEDIFAST INC (MED) vs. Nutraceutical International Corporation (NUTR) Head to Head Review - June 27 at 6:22 PM logoMedifast, Inc. : MED-US: Dividend Analysis : June 23rd, 2017 (record date) : By the numbers : June 21, 2017 - June 21 at 7:39 PM logoMedifast, Inc. :MED-US: Earnings Analysis: Q1, 2017 By the Numbers : June 21, 2017 - June 21 at 7:39 PM logoTake Shape For Life® Named to 2017 Direct Selling Association Top 20 List - June 20 at 7:30 PM logoDividend Coverage: This Nutrition and Weight Loss Company has a Dividend Yield of 3.02%; Will Trade Ex-Dividend on June 21, 2017 - June 20 at 7:30 PM logoMEDIFAST INC Declares Quarterly Dividend of $0.32 (MED) - June 16 at 1:22 PM logoBRIEF-Medifast Inc may repurchase up to 850,000 shares of common stock - June 15 at 2:56 AM logoMedifast® Announces 10b5-1 Plan to Facilitate Continued Share Repurchases - June 14 at 9:36 AM logoExclusive: Medifast explores move from Baltimore County to Harbor East - June 7 at 6:08 PM logoMedifast Inc (MED) Expected to Post Earnings of $0.53 Per Share - June 1 at 8:20 PM logo5 Must See Earnings Charts - May 24 at 10:51 AM logoTerra's Kitchen raising $5 million to fuel growth, hiring - May 13 at 8:56 AM



Medifast (MED) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by Staff